Mainstay Healthcare Partners Expands Advisory Platform with Formation of Strategic Advisory Board Reflecting Its Philosophy of Deep, Experience-Driven Partnership

Advisors bring deep experience and leadership across healthcare services and healthtech

• Michael Blau — Leading healthcare corporate and regulatory attorney
• Chuck Farkas — Senior strategy leader advising CEOs and boards
• Ann Gallo — Veteran public and private markets healthcare investor
• Mike Matteo — Experienced healthcare growth and market executive

BOSTON--(BUSINESS WIRE)--Mainstay Healthcare Partners (“Mainstay”), a strategic advisory and investment firm serving healthcare services and health technology companies, today announced the formation of its Strategic Advisory Board, bringing together industry-leading operators, investors and executive advisors who embody Mainstay’s philosophy of trusted, long-term partnership grounded in real operating experience.

The creation of this team of strategic advisors reinforces Mainstay’s approach of working as true partners to leadership teams rooted in close collaboration, shared accountability and deeply informed judgment earned through decades of experience across the healthcare services and technology landscape.

“Mainstay was built to be the kind of partner we wished existed that combines operating credibility, healthcare depth and trusted relationships,” said Dana McNally, Co-Founder and Partner. “Our Advisory Board reflects that vision. These leaders bring the experience, objectivity and perspective companies need as they scale and advance forward. They are joining Mainstay to lean in and support our work which will ultimately enhance our impact for clients.”

Strategic Advisory Board Members — Summary Profiles

Michael Blau – Strategic Advisor

Michael Blau is a retired partner with Foley & Lardner LLP. His practice focused on advising clients on corporate and regulatory healthcare matters, including mergers, acquisitions, affiliations, financing transactions, contracting, and the formation of provider groups, networks, alliances, and joint ventures.

He served as the chair of Foley Lardner’s Industry Teams Department and previously chaired the firm’s Research and Development Group and its Health Care Industry Team Planning Committee. Prior to joining Foley, Michael served as partner-in-charge of the Health Law Department in the Boston office of McDermott Will & Emery LLP.

Chuck Farkas – Strategic Advisor

Chuck Farkas is a long-time senior leader in Bain & Company’s Healthcare & Life Sciences, Financial Services, and Strategy practices. Since joining Bain in 1979 and becoming a partner in 1985, Chuck has advised CEOs and senior executives globally on growth strategy, leadership, organizational effectiveness and change management.

He has served as Global Leader of Bain’s Financial Services practice, North American Head of Healthcare, and Managing Partner of Bain Canada. Chuck is the author of Maximum Leadership and has published in the Harvard Business Review, Fortune, In Vivo and other leading outlets.

Chuck currently serves on the boards of CONMED Corporation, Intuitive Health, Medicinal Genomics, Medzown, and Shields Health. He holds a BA from Princeton University and an MBA from Harvard Business School and was an ITT International Fellow through the Fulbright program.

Ann Gallo – Strategic Advisor

Ann Gallo has been an active healthcare investor and advisor for nearly 30 years. She is the Founder and CEO of ACG Advisory, where she partners with high-growth healthcare service and technology companies. Previously, Ann spent over 25 years at Wellington Management Company, LLP, where she served as senior managing director, partner and investment team leader of the firm’s $60 billion healthcare franchise.

At Wellington, she managed diversified healthcare portfolios, researched healthcare services and medical technology companies and helped launch the firm’s late-stage private equity franchise. Ann served on numerous governance, operating, and oversight committees and today serves on the Boards of Piper Sandler, Sword Health and Boston Ballet.

Her earlier roles include senior analyst positions with Alex. Brown & Sons and Piper Sandler, as well as finance roles at Citibank N.A. and Coopers & Lybrand. She holds a master’s degree in finance and applied economics from MIT and a bachelor’s degree in accounting from Boston College.

Mike Matteo – Strategic Advisor

Mike Matteo is a Principal at MCM Consulting, LLC and a senior advisor to InTandem Capital Partners. He previously served as a Venture Partner at Oak HC/FT, where he supported early-stage healthcare companies on strategy and go-to-market execution.

Mike was formerly President of Grand Rounds (now Included Health), leading all growth and client-facing teams. Prior to that, he spent nearly two decades at UnitedHealth Group in roles including Chief Client Officer at OptumRx, CEO of UHC National Accounts and Public Sector and Chief Growth Officer at Optum.

He began his career at The Travelers Insurance Company, holds a bachelor’s degree from the College of the Holy Cross, and completed Columbia University’s Graduate School of Business Executive Development Program.

Deepening Mainstay’s Growth Advisory and Capital Markets Advisory Platforms

Reflecting its strategic approach and the needs of the companies it supports, Mainstay has organized its business into two integrated advisory platforms: Growth Advisory and Capital Markets Advisory. Each is designed to guide clients through different phases of growth, transformation and market readiness.

Growth Advisory
Supporting healthcare organizations with strategy, go-to-market execution, sales operations design, industry connectivity and partnership formation.

We help teams define where and how to win, build scalable commercial infrastructure and accelerate market momentum.

Capital Markets Advisory
Guiding companies through the full capital lifecycle, including IPO readiness, investor narrative development, stakeholder alignment, governance evolution, KPI discipline, and long-term value creation.

We bring insight calibrated by deep experience with the healthcare services and healthtech public markets.

Healthcare organizations today face unprecedented pressure to grow, differentiate, and perform. Leadership teams need advisory partners who understand their world, who bring judgment grounded in experience, and who can work alongside them to move the business forward. That is the foundation of Mainstay’s model. We are deeply engaged in the market partnering with clients, collaborating with executives across markets, and staying tightly connected to the industry developments so that we can deliver meaningful impact in real time.

“Our clients trust us because we show up as hands-on partners. We sit alongside executive teams and boards to help navigate complexity with clarity,” said Kevin M. Ban, MD, Co-Founder and Partner. “This Advisory Board strengthens our ability to deliver that level of partnership.”

“Today’s market recognizes and rewards discipline, transparency and credible execution,” said Dave Khtikian, Co-Founder and Partner. “Our Advisory Board blends rigorous technical insight with the kind of strategic perspective that only comes from decades of operating and investing experience. Their guidance will be invaluable to the companies we support as they work to build durable performance and long-term stakeholder confidence.”

About Mainstay Healthcare Partners
Mainstay Healthcare Partners is a strategic advisory and investment firm serving healthcare services and health technology companies. The firm provides top-of-house advisory grounded in real operator, investor, and clinical experience across growth advisory, capital markets advisory, and executive partnership.

For more information about Mainstay Healthcare Partners or to explore partnership opportunities, visit www.mainstayhp.com or contact at [e-mail].